217 related articles for article (PubMed ID: 18587385)
1. An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.
Benny O; Fainaru O; Adini A; Cassiola F; Bazinet L; Adini I; Pravda E; Nahmias Y; Koirala S; Corfas G; D'Amato RJ; Folkman J
Nat Biotechnol; 2008 Jul; 26(7):799-807. PubMed ID: 18587385
[TBL] [Abstract][Full Text] [Related]
2. Broad spectrum antiangiogenic treatment for ocular neovascular diseases.
Benny O; Nakai K; Yoshimura T; Bazinet L; Akula JD; Nakao S; Hafezi-Moghadam A; Panigrahy D; Pakneshan P; D'Amato RJ
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824139
[TBL] [Abstract][Full Text] [Related]
3. Hitting the mother lode of tumor angiogenesis.
James D; Rabbany S; Rafii S
Nat Biotechnol; 2008 Jul; 26(7):769-70. PubMed ID: 18612297
[No Abstract] [Full Text] [Related]
4. Angiogenesis research. Cancer drugs found to work in new way.
Barinaga M
Science; 2000 Apr; 288(5464):245. PubMed ID: 10777399
[No Abstract] [Full Text] [Related]
5. Clinical trials of antiangiogenic agents.
Twardowski P; Gradishar WJ
Curr Opin Oncol; 1997 Nov; 9(6):584-9. PubMed ID: 9370081
[TBL] [Abstract][Full Text] [Related]
6. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
[TBL] [Abstract][Full Text] [Related]
7. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis.
Brem H; Gresser I; Grosfeld J; Folkman J
J Pediatr Surg; 1993 Oct; 28(10):1253-7. PubMed ID: 7505321
[TBL] [Abstract][Full Text] [Related]
8. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
Beecken WD; Fernandez A; Joussen AM; Achilles EG; Flynn E; Lo KM; Gillies SD; Javaherian K; Folkman J; Shing Y
J Natl Cancer Inst; 2001 Mar; 93(5):382-7. PubMed ID: 11238700
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of the anti-angiogenesis drug TNP-470.
Gervaz P; Fontolliet C
Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
Gervaz P; Scholl B; Padrun V; Gillet M
Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
[TBL] [Abstract][Full Text] [Related]
12. TNP-470 promotes initial vascular sprouting in xenograft tumors.
Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of TNP-470 in combination with BCNU on tumor growth of human glioblastoma xenografts.
Yao D; Zhao H; Zhang F; Chen J; Jiang X; Zhu X
J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):757-61. PubMed ID: 21181367
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato M; Takaoka K
Bone; 1998 Feb; 22(2):99-105. PubMed ID: 9477232
[TBL] [Abstract][Full Text] [Related]
17. Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes.
Landuyt W; Theys J; Nuyts S; Drijkoningen M; Fowler J; Reijnders A; Liekens S; Neyts J; de Bruijn E; Anné J; Lambin P
Cancer Invest; 2001; 19(1):35-40. PubMed ID: 11291554
[TBL] [Abstract][Full Text] [Related]
18. A potential use of a synthetic retinoid TAC-101 as an orally active agent that blocks angiogenesis in liver metastases of human stomach cancer cells.
Oikawa T; Murakami K; Sano M; Shibata J; Wierzba K; Yamada Y
Jpn J Cancer Res; 2001 Nov; 92(11):1225-34. PubMed ID: 11714448
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Kakeji Y; Teicher BA
Invest New Drugs; 1997; 15(1):39-48. PubMed ID: 9195288
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
Jia L; Zhang MH; Yuan SZ; Huang WG
World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
